Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec:72:87-98.
doi: 10.1016/j.semcdb.2017.10.031.

Myogenic progenitor specification from pluripotent stem cells

Alessandro Magli  1 , Rita R C Perlingeiro  2
Affiliations
Review

Myogenic progenitor specification from pluripotent stem cells

Alessandro Magli et al. Semin Cell Dev Biol. 2017 Dec.

Abstract

Pluripotent stem cells represent important tools for both basic and translational science as they enable to study mechanisms of development, model diseases in vitro and provide a potential source of tissue-specific progenitors for cell therapy. Concomitantly with the increasing knowledge of the molecular mechanisms behind activation of the skeletal myogenic program during embryonic development, novel findings in the stem cell field provided the opportunity to begin recapitulating in vitro the events occurring during specification of the myogenic lineage. In this review, we will provide a perspective of the molecular mechanisms responsible for skeletal myogenic commitment in the embryo and how this knowledge was instrumental for specifying this lineage from pluripotent stem cells. In addition, we will discuss the current limitations for properly recapitulating skeletal myogenesis in the petri dish, and we will provide insights about future applications of pluripotent stem cell-derived myogenic cells.

Keywords: BMP inhibitor; Cell therapy; Disease modeling; ES cells; GSK3 inhibitor; Mesoderm specification; Muscle development; Muscle regeneration; Myf5; MyoD; Myogenesis; Myogenic progenitor; Paraxial mesoderm; Pax3; Pax7; Pluripotent stem cells; Somite; TGFβ inhibitor; WNT activation; iPS cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1
timeline of selected findings that contributed to the actual status of the field. References are indicated by the numbers in parentheses.
See this image and copyright information in PMC

References

    1. Constantinides PG, Jones PA, Gevers W. Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment. Nature. 1977;267(5609):364–6. - PubMed
    1. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 1987;51(6):987–1000. - PubMed
    1. Lassar AB, Paterson BM, Weintraub H. Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell. 1986;47(5):649–56. - PubMed
    1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76. - PubMed
    1. Shi Y, Inoue H, Wu JC, Yamanaka S. Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov. 2017;16(2):115–130. - PMC - PubMed

Publication types

Substances